This week’s newsletter covers the passing of legendary cannabis breeder Sam the Skunkman, the growing risks of the THC potency arms race, new hemp retail regulations, and the latest research on CBD, CBG, and psilocybin.
Noteworthy Read
Legendary Cannabis Breeder David Watson, aka Sam the Skunkman, Dies (Cannabis Business Times)
David Watson, better known as Sam the Skunkman, has passed away, leaving behind a legacy as one of the most influential cannabis breeders in history. His work with Skunk #1 helped shape modern cannabis genetics and the industry as we know it today.
More Noteworthy Reading
The Race for All-Powerful Pot (Spokesman-Review)
As cannabis cultivators push THC levels to new extremes, concerns grow over potency, safety, and regulatory oversight. This article examines the race to create ultra-potent cannabis strains and the implications for consumers and the industry.
Farm Bill Doesn’t Preempt States from Restricting Intoxicating Hemp Retail Sales (NORML)
A federal court ruled that the 2018 Farm Bill does not prevent states from enacting their own restrictions on intoxicating hemp-derived products, reinforcing states’ rights to regulate their cannabis and hemp markets.
CBD Treatment Leads to Lipid Changes in Leukemia Cells (Pinnacle Gazette)
A study finds that cannabidiol (CBD) alters lipid metabolism in leukemia cells, potentially affecting cancer cell survival and opening new avenues for cannabinoid-based cancer treatments.
Detecting Counterfeit Cannabis Edibles with Spectroscopy (News-Medical.net)
Researchers are using spectroscopy to identify counterfeit cannabis edibles, highlighting concerns about mislabeled potency and contamination in the cannabis market.
Research Round-Up
Neuroprotective Effects of Psilocybin in a Rat Model of Stroke (PubMed)
A study demonstrates that psilocybin provides neuroprotective benefits in a rat model of stroke, suggesting potential therapeutic applications for stroke recovery and brain repair.
Read more
View more in Psychedelics
CBG Treatment Shows Promising Results Against Human Colorectal Cancer Cells (Journal of Pharmacopuncture)
This study suggests that Cannabigerol (CBG) exhibits strong anti-proliferative effects and induces apoptosis in colorectal cancer cells, adding to the growing body of evidence supporting its potential as an anticancer agent.
A heartfelt thank you to all of the CBD brands whose generous support makes it possible for Project CBD to shine a light on the groundbreaking plant medicine research shaping our world. We are deeply grateful for your partnership.
